Thursday, October 29, 2020
Public Relations

Cystic Fibrosis Foundation launches $20 million CF incubator


In partnership with the Longwood Fund, a biotech-focused venture capital firm, the Cystic Fibrosis Foundation in Bethesda, Maryland, has announced the launch of a $20 million cystic fibrosis incubator.

Launched as part of the foundation’s $500 million Path to a Cure initiative, the effort is aimed at accelerating the development of CF programs in select Longwood Fund companies. Through the incubator, the foundation will have the opportunity to provide seed-stage funding to new companies within Longwood’s general fund, as well as the option to continue investing in those companies in future fundraising rounds.

“The Cystic Fibrosis Foundation has a legacy of making bold commitments, including early-stage funding to develop breakthrough therapies for people with cystic fibrosis and to drive progress toward a cure,” said Cystic Fibrosis Foundation president and CEO Michael P. Boyle. “This collaboration marks an exciting evolution in our long-standing approach to venture philanthropy and will amplify our efforts to draw the best scientific minds and technologies into CF and accelerate our Path to a Cure.”

Related posts

African Union launches the first edition of the Africa Migration Report in collaboration with IOM

Viwe Tyolwana

Vodacom zero-rates new COVID Alert SA app

Viwe Tyolwana

Lockdown-inspired digital innovations are here to stay

Viwe Tyolwana